The significant duration of the patient's hyperglycemia secondary to NDM highlights the importance of early genetic testing for this disease as the switch from insulin to SU was ultimately only recommended due to the insight provided by genetic testing. The gene discussed is INS; the disease is neonatal diabetes mellitus.